Sandu Pharmaceuticals (BOM:524703) Other Current Liabilities: ₹0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524703 Sandu Pharmaceuticals Ltd BOM:524703
71 GF Score
Price ₹37.74
GF Value ₹53.47
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sandu Pharmaceuticals Other Current Liabilities?

Sandu Pharmaceuticals BOM:524703 -1.20% 71 Other Current Liabilities is ₹0.0 Mil as of Jun. 2026. GuruFocus rates BOM:524703 with a GF Score™ of 71/100 and a GF Value™ of ₹53.47 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Sandu Pharmaceuticals's other current liabilities for the quarter that ended in Jun. 2026 was ₹0.0 Mil.

Sandu Pharmaceuticals's quarterly other current liabilities increased from Dec. 2025 (₹0.0 Mil) to Mar. 2026 (₹50.3 Mil) but then declined from Mar. 2026 (₹50.3 Mil) to Jun. 2026 (₹0.0 Mil).

Sandu Pharmaceuticals's annual other current liabilities increased from Mar. 2024 (₹59.1 Mil) to Mar. 2025 (₹69.7 Mil) but then declined from Mar. 2025 (₹69.7 Mil) to Mar. 2026 (₹50.3 Mil).

Sandu Pharmaceuticals Other Current Liabilities Related Terms

Sandu Pharmaceuticals Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Sandu Pharmaceuticals's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandu Pharmaceuticals Other Current Liabilities Chart

Sandu Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 46.12 51.99 59.14 69.65 50.35

Sandu Pharmaceuticals Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 85.85 0.00 50.35 0.00
BOM:524703
71GF Score
Sandu Pharmaceuticals Ltd BOM:524703
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandu Pharmaceuticals Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₹0.0 Mil mean?
Sandu Pharmaceuticals (BOM:524703) has a Other Current Liabilities of ₹0.0 Mil as of Jun. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Sandu Pharmaceuticals.
Is Sandu Pharmaceuticals' Other Current Liabilities too high?
Sandu Pharmaceuticals' current Other Current Liabilities is ₹0.0 Mil. Overall, Sandu Pharmaceuticals has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sandu Pharmaceuticals' Other Current Liabilities compare to ZTS?
Sandu Pharmaceuticals' Other Current Liabilities of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Sandu Pharmaceuticals. Sandu Pharmaceuticals's current Other Current Liabilities is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandu Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Sandu Pharmaceuticals (BOM:524703) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹53.47, compared to a current price of ₹37.74 — trading 29.4% below its estimated fair value. The current Other Current Liabilities is ₹0.0 Mil. Sandu Pharmaceuticals' overall GF Score™ is 71/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Sandu Pharmaceuticals (BOM:524703), the current Other Current Liabilities is ₹0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sandu Pharmaceuticals (BOM:524703) Overvalued in 2026?

Based on GuruFocus' analysis, Sandu Pharmaceuticals stock appears to be undervalued. The current stock price of ₹37.74 is trading 29.4% below its estimated GF Value™ of ₹53.47. GuruFocus considers Sandu Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for BOM:524703:

  • Other Current Liabilities: ₹0.0 Mil
  • GF Value™: ₹53.47 vs. price of ₹37.74 (29.4% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the BOM:524703 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sandu Pharmaceuticals Business Description

Address D. K. Sandu Marg, Sandu Nagar, Chembur, Mumbai, MH, IND, 400 071
Sandu Pharmaceuticals Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and sales of Ayurvedic pharmaceutical products.
71GF Score

Get the complete analysis for BOM:524703

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹37.74
Price
₹53.47
GF Value